Association between FcγRIIa-R131 allotype and bacteremic pneumococcal pneumonia

Clinical Infectious Diseases

Volumn 30, Issue 1, 2000, Pages 25-28

  Yee, Arthur M F ^a   Phan, Hoang M ^c   Zuniga, Ricardo ^a   Salmon, Jane E ^a   Musher, Daniel M ^b,c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; CELL SURFACE RECEPTOR; IMMUNOGLOBULIN ALLOTYPE; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G2; FC GAMMA RECEPTOR IIA; FC RECEPTOR; IMMUNOGLOBULIN G; LEUKOCYTE ANTIGEN;

AMINO ACID SUBSTITUTION; ARTICLE; BACTEREMIA; BINDING AFFINITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC RISK; GENOTYPE; HOMOZYGOSITY; HUMAN; LOBAR PNEUMONIA; MAJOR CLINICAL STUDY; NEUTROPHIL; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; ALLELE; GENETICS; HOMOZYGOTE; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PROSPECTIVE STUDY;

ALLELES; ANTIGENS, CD; BACTEREMIA; GENE FREQUENCY; GENOTYPE; HOMOZYGOTE; HUMANS; IMMUNOGLOBULIN G; PNEUMONIA, PNEUMOCOCCAL; PROSPECTIVE STUDIES; RECEPTORS, IGG;

EID: 0033629719     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313588     Document Type: Article

References (25)

1. Clark MR, Stuart SG, Kimberly RP Ory PA, Goldstein IM. A single amino acid distinguishes the high-responder from the low-responder form of FC receptor II on human monocytes. Eur J Immunol 1991; 21:1911-6.
2. Warmerdam PAM, van de Winkel JGJ, Vlug A, Westerdaal NAC, Capel PJA. A single amino acid in the second Ig-like domain of the human Fcγ receptor II is critical for human IgG2 binding. J Immunol 1991; 147:1338-43.
3. Ory PA, Goldstein IM, Kwoh EE, Clarkson SB. Characterization of polymorphic forms of Fc receptor III on human neutrophils. J Clin Invest 1989; 83:1676-81.
4. Salmon JE, Edberg JC, Kimberly RP, Mensa E, Ryan R. Fcγ receptor III on human neutrophils: allelic variants have functionally distinct capacities. J Clin Invest 1990; 85:1287-95.
5. Warmerdam PAM, van de Winkel JGJ, Vlug A, Westerdaal NAC, Capel PJA. A single amino acid in the second Ig-like domain of the human Fcγ receptor II is critical for human IgG2 binding. J Immunol 1991; 147:1338-43.
6. Salmon JE, Edberg JC, Brogle NL, Kimberly RP. Allelic polymorphisms of human Fcγ receptor IIIB: independent mechanisms for differences in human phagocyte function. J Clin Invest 1992; 89:1274-12.
7. Parren PWHI, Warmerdam PAM, Boeije LCM, et al. On the interaction of IgG subclasses with the low affinity FcγRIIa (CD32) on human monocytes, neutrophils, and platelets. J Clin Invest 1992; 90:1537-46.
8. Noya FDJ, Baker CJ, Edwards MS. Neutrophil Fc receptor participation in phagocytosis of type III group B streptococci. Infect Immun 1993; 61:1415-20.
9. Bredius RG, de Vries CEE, Troelstra A, et al. Phagocytosis of Staphylococcus aureus and Haemophilus influenzae type B opsonized with polyclonal human IgG1 and IgG2 antibodies. J Immunol 1993; 151:1463-72.
10. Sanders LAM, Feldman RG, Voorhorst-Ogink MD, et al. Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils. Infect Immun 1995; 63:73-81.
11. Heffron R. Pneumonia: with special reference to Pneumococcus lobar pneumonia. A Commonwealth Fund Book, 1939. Reprinted Cambridge, MA: Harvard University Press, 1979.
12. Austrian R, Douglas RM, Schiffman G, et al. Prevention of pneumococcal pneumonia by vaccination. Trans Assoc Am Physicians 1976; 89:184-92.
13. Musher DM. Streptococcus pneumoniae. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious disease. 4th ed. New York: John Wiley & Sons, 1994:1811-26.
14. McDaniel LS, Yother J, Vijayakumar M, McGarry L, Guild WR, Briles DE. Use of insertional activation to facilitate studies of biological properties of pneumococcal surface protein A (PspA). J Exp Med 1987; 165:381-94.
15. McDaniel LS, Sheffield JS, Delucchi P, Briles DE. PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one serotype. Infect Immun 1991; 59:222-8.
16. Paton JC, Berry AM, Lock A. Molecular analysis of putative pneumococcal virulence proteins. Microb Drug Resist 1997; 3:1-10.
17. Salmon JE, Millard S, Schacter LA, et al. FcγRIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest 1996; 97:1348-54.
18. Osborn JM, Chacko GW, Brandt JT, Anderson CL. Ethnic variation in frequency of an allelic polymorphism of human FcγRIIA determined with allele specific oligonucleotide probes. J Immunol Methods 1994; 173:207-17.
19. Duits AJ, Bootsma H, Derksen RHWM, et al. Skewed distribution of IgG Fc receptor Iia (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Arthritis Rheum 1995; 38:1832-6.
20. Yee AMF, Ng SC, Sobel RE, Salmon JE. FcγRIIA polymorphism as a risk factor for invasive pneumococcal infections in systemic lupus erythematosus. Arthritis Rheum 1997; 40:1180-1.
21. Salmon JE, Brogle NL, Edberg JC, Kimberly RP. Fcγ receptor III induces actin polymerization in human neutrophils and primes phagocytosis mediated by Fcγ receptor II. J Immunol 1991; 146:997-1004.
22. Bredius RGM, Derkx BHF, Fijen CAP, et al. Fcγ receptor Iia (CD32) polymorphism in fulminant meningococcal septic shock in children. J Infect Dis 1994; 170:848-53.
23. Rodriguez ME, van der Pol W-L, Sanders LAM, van de Winkel JGJ. Crucial role of FcγRIIa (CD32) in assessment of functional anti-Streptococcus pneumoniae antibody activity in human sera. J Infect Dis 1999; 179:423-33.
24. Fijen CAP, Bredius RGM, Kuijper EJ. Polymorphism of IgG Fc-receptors in meningococcal disease: risk marker in complement deficient patients. Ann Intern Med 1993; 119:636.
25. Platonov AE, Shipulin GA, Vershinina IV, Dankert J, van de Winkel JGJ, Kuijper EJ. Association of human FcγRIIa (CD32) polymorphism with susceptibility to and severity of meningococcal disease. Clin Infect Dis 1998; 27:746-50.